223 related articles for article (PubMed ID: 10620111)
1. Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations.
Bishop JA; Wachsmuth RC; Harland M; Bataille V; Pinney E; MacK P; Baglietto L; Cuzick J; Bishop DT
J Invest Dermatol; 2000 Jan; 114(1):28-33. PubMed ID: 10620111
[TBL] [Abstract][Full Text] [Related]
2. Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype.
Nielsen K; Harbst K; Måsbäck A; Jönsson G; Borg A; Olsson H; Ingvar C
Melanoma Res; 2010 Aug; 20(4):266-72. PubMed ID: 20526219
[TBL] [Abstract][Full Text] [Related]
3. Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families.
Taylor NJ; Mitra N; Goldstein AM; Tucker MA; Avril MF; Azizi E; Bergman W; Bishop DT; Bressac-de Paillerets B; Bruno W; Calista D; Cannon-Albright LA; Cuellar F; Cust AE; Demenais F; Elder DE; Gerdes AM; Ghiorzo P; Grazziotin TC; Hansson J; Harland M; Hayward NK; Hocevar M; Höiom V; Ingvar C; Landi MT; Landman G; Larre-Borges A; Leachman SA; Mann GJ; Nagore E; Olsson H; Palmer JM; Perić B; Pjanova D; Pritchard A; Puig S; van der Stoep N; Wadt KAW; Whitaker L; Yang XR; Newton Bishop JA; Gruis NA; Kanetsky PA;
J Invest Dermatol; 2017 Dec; 137(12):2606-2612. PubMed ID: 28830827
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome.
Lynch HT; Brand RE; Hogg D; Deters CA; Fusaro RM; Lynch JF; Liu L; Knezetic J; Lassam NJ; Goggins M; Kern S
Cancer; 2002 Jan; 94(1):84-96. PubMed ID: 11815963
[TBL] [Abstract][Full Text] [Related]
5. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.
Begg CB; Orlow I; Hummer AJ; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Gruber SB; Anton-Culver H; Zanetti R; Gallagher RP; Dwyer T; Rebbeck TR; Mitra N; Busam K; From L; Berwick M;
J Natl Cancer Inst; 2005 Oct; 97(20):1507-15. PubMed ID: 16234564
[TBL] [Abstract][Full Text] [Related]
6. [From gene to disease; from p16 to melanoma].
Gruis NA; Bergman W
Ned Tijdschr Geneeskd; 2000 Oct; 144(44):2100-2. PubMed ID: 11103670
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families.
de Snoo FA; Hottenga JJ; Gillanders EM; Sandkuijl LA; Jones MP; Bergman W; van der Drift C; van Leeuwen I; van Mourik L; Huurne JA; Frants RR; Willemze R; Breuning MH; Trent JM; Gruis NA
Eur J Hum Genet; 2008 Sep; 16(9):1135-41. PubMed ID: 18398432
[TBL] [Abstract][Full Text] [Related]
8. Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families.
Goldstein AM; Martinez M; Tucker MA; Demenais F
Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):889-94. PubMed ID: 11008905
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the neoplastic phenotype in the familial atypical multiple-mole melanoma-pancreatic carcinoma syndrome.
Rulyak SJ; Brentnall TA; Lynch HT; Austin MA
Cancer; 2003 Aug; 98(4):798-804. PubMed ID: 12910525
[TBL] [Abstract][Full Text] [Related]
10. CDKN2A mutations in multiple primary melanomas.
Monzon J; Liu L; Brill H; Goldstein AM; Tucker MA; From L; McLaughlin J; Hogg D; Lassam NJ
N Engl J Med; 1998 Mar; 338(13):879-87. PubMed ID: 9516223
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic cancer-associated gene polymorphisms in a nation-wide cohort of p16-Leiden germline mutation carriers; a case-control study.
Potjer TP; van der Stoep N; Houwing-Duistermaat JJ; Konings IC; Aalfs CM; van den Akker PC; Ausems MG; Dommering CJ; van der Kolk LE; Maiburg MC; Spruijt L; Wagner A; Vasen HF; Hes FJ
BMC Res Notes; 2015 Jun; 8():264. PubMed ID: 26111702
[TBL] [Abstract][Full Text] [Related]
12. Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families.
Chaudru V; Chompret A; Bressac-de Paillerets B; Spatz A; Avril MF; Demenais F
J Natl Cancer Inst; 2004 May; 96(10):785-95. PubMed ID: 15150307
[TBL] [Abstract][Full Text] [Related]
13. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma.
Pho L; Grossman D; Leachman SA
Curr Opin Oncol; 2006 Mar; 18(2):173-9. PubMed ID: 16462187
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal assessment of the nevus phenotype in a melanoma kindred.
Florell SR; Meyer LJ; Boucher KM; Porter-Gill PA; Hart M; Erickson J; Cannon-Albright LA; Pershing LK; Harris RM; Samlowski WE; Zone JJ; Leachman SA
J Invest Dermatol; 2004 Sep; 123(3):576-82. PubMed ID: 15304099
[TBL] [Abstract][Full Text] [Related]
15. Surveillance of second-degree relatives from melanoma families with a CDKN2A germline mutation.
van der Rhee JI; Boonk SE; Putter H; Cannegieter SC; Flinterman LE; Hes FJ; de Snoo FA; Mooi WJ; Gruis NA; Vasen HF; Kukutsch NA; Bergman W
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1771-7. PubMed ID: 23897584
[TBL] [Abstract][Full Text] [Related]
16. A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs.
Zhu G; Duffy DL; Eldridge A; Grace M; Mayne C; O'Gorman L; Aitken JF; Neale MC; Hayward NK; Green AC; Martin NG
Am J Hum Genet; 1999 Aug; 65(2):483-92. PubMed ID: 10417291
[TBL] [Abstract][Full Text] [Related]
17. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.
Hashemi J; Platz A; Ueno T; Stierner U; Ringborg U; Hansson J
Cancer Res; 2000 Dec; 60(24):6864-7. PubMed ID: 11156381
[TBL] [Abstract][Full Text] [Related]
18. Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.
Goldstein AM; Struewing JP; Chidambaram A; Fraser MC; Tucker MA
J Natl Cancer Inst; 2000 Jun; 92(12):1006-10. PubMed ID: 10861313
[TBL] [Abstract][Full Text] [Related]
19. Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2A p.D84V (c.251A>T) mutation in melanoma-prone families from Italy.
Borroni RG; Manganoni AM; Grassi S; Grasso M; Diegoli M; Giorgianni C; Favalli V; Pavoni L; Cespa M; Arbustini E
Melanoma Res; 2017 Apr; 27(2):97-103. PubMed ID: 28060055
[TBL] [Abstract][Full Text] [Related]
20. Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
Demenais F; Mohamdi H; Chaudru V; Goldstein AM; Newton Bishop JA; Bishop DT; Kanetsky PA; Hayward NK; Gillanders E; Elder DE; Avril MF; Azizi E; van Belle P; Bergman W; Bianchi-Scarrà G; Bressac-de Paillerets B; Calista D; Carrera C; Hansson J; Harland M; Hogg D; Höiom V; Holland EA; Ingvar C; Landi MT; Lang JM; Mackie RM; Mann GJ; Ming ME; Njauw CJ; Olsson H; Palmer J; Pastorino L; Puig S; Randerson-Moor J; Stark M; Tsao H; Tucker MA; van der Velden P; Yang XR; Gruis N;
J Natl Cancer Inst; 2010 Oct; 102(20):1568-83. PubMed ID: 20876876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
